Hambleton Julie

Insider profile

Performance

Overall performance
3.9

Performance over holding periods
3.9
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Hambleton Julie's trades of Springworks Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-12 2025-02-10 PlS Planned sale
32,157 +9.5%
355.01
US$844,686
32,157 +9.5% 355.01 US$844,686
2025-02-10 2025-02-10 PrS Proposed sale
52,278
379.21
US$434,215
52,278 379.21 US$434,215
2024-07-29 2024-07-25 PlS Planned sale
16,876 -6.4%
266.41
US$3,142,983
16,876 -6.4% 266.41 US$3,142,983
2024-07-25 2024-07-25 PrS Proposed sale
15,132
13.95
US$211,079
15,132 13.95 US$211,079
2024-06-05 2024-06-03 PlS Planned sale
20 -0.5%
42.09
US$842
20 -0.5% 42.09 US$842
2024-06-05 2024-06-03 PlS Planned sale
931 -18.5%
41.49
US$38,629
931 -18.5% 41.49 US$38,629
2024-06-05 2024-06-03 PlS Planned sale
751 -13.0%
40.57
US$30,465
751 -13.0% 40.57 US$30,465
2024-06-05 2024-06-03 PlS Planned sale
2,946 -33.7%
39.41
US$116,111
2,946 -33.7% 39.41 US$116,111
2024-06-03 2024-06-03 PrS Proposed sale
4,648
41.44
US$192,613
4,648 41.44 US$192,613
2023-07-21 2023-07-19 PlS Planned sale
2,418 -34.2%
29.31
US$70,876
2,418 -34.2% 29.31 US$70,876
2023-06-22 2023-06-20 PlS Planned sale
2,400 -25.4%
26.92
US$64,603
2,400 -25.4% 26.92 US$64,603
2023-06-20 2023-06-20 PrS Proposed sale
4,818
27.00
US$130,086
4,818 27.00 US$130,086
2023-03-16 2023-03-15 S Sale
1,106 -18.7%
31.50
US$34,841
1,106 -18.7% 31.50 US$34,841
2021-06-03 2021-06-01 PlS Planned sale
2,000 -40.0%
80.00
US$160,000
2,000 -40.0% 80.00 US$160,000
2019-09-20 2019-09-18 B Purchase
5,000 +inf%
18.31
US$91,550
5,000 +inf% 18.31 US$91,550